Idexx Laboratories Inc /De financial data

Symbol
IDXX on Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
Location
One Idexx Drive, Westbrook, ME
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Oct 31, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 148 % +27.5%
Quick Ratio 38.2 % +2.52%
Debt-to-equity 114 % -42.9%
Return On Equity 125 % +21.1%
Return On Assets 25.9 % -9.41%
Operating Margin 28.9 % -3.76%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 81.9M shares -1.41%
Common Stock, Shares, Outstanding 82M shares -1.24%
Entity Public Float 41.3B USD +42.7%
Common Stock, Value, Issued 10.8M USD +0.23%
Weighted Average Number of Shares Outstanding, Basic 82.3M shares -0.95%
Weighted Average Number of Shares Outstanding, Diluted 83.1M shares -1.12%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 3.84B USD +7.16%
Cost of Revenue 1.51B USD +4.95%
Research and Development Expense 214M USD +17.2%
Selling and Marketing Expense 580M USD +4.4%
General and Administrative Expense 428M USD +29%
Operating Income (Loss) 1.11B USD +3.12%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 1.09B USD +5.64%
Income Tax Expense (Benefit) 227M USD +7.02%
Net Income (Loss) Attributable to Parent 866M USD +5.29%
Earnings Per Share, Basic 10.5 USD/shares +5.65%
Earnings Per Share, Diluted 10.4 USD/shares +5.71%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 309M USD -6.95%
Accounts Receivable, after Allowance for Credit Loss, Current 511M USD +12.9%
Inventory, Net 390M USD -1.06%
Other Assets, Current 224M USD +8.84%
Assets, Current 1.43B USD +3.58%
Deferred Income Tax Assets, Net 135M USD +95.3%
Property, Plant and Equipment, Net 718M USD +4.46%
Operating Lease, Right-of-Use Asset 121M USD +2.78%
Intangible Assets, Net (Excluding Goodwill) 107M USD +22.7%
Goodwill 412M USD +13.9%
Other Assets, Noncurrent 559M USD +24.7%
Assets 3.35B USD +8.57%
Accounts Payable, Current 111M USD -1.78%
Employee-related Liabilities, Current 159M USD +0.52%
Accrued Liabilities, Current 511M USD +21.6%
Contract with Customer, Liability, Current 38.4M USD +3.09%
Liabilities, Current 1.01B USD +4.02%
Contract with Customer, Liability, Noncurrent 26.8M USD -3.4%
Accrued Income Taxes, Noncurrent 30.5M USD -25.4%
Deferred Income Tax Liabilities, Net 5.66M USD -46.6%
Operating Lease, Liability, Noncurrent 103M USD +1.92%
Other Liabilities, Noncurrent 62.9M USD +4.43%
Liabilities 1.73B USD -3.15%
Accumulated Other Comprehensive Income (Loss), Net of Tax -76M USD -1.44%
Retained Earnings (Accumulated Deficit) 5.12B USD +20.4%
Stockholders' Equity Attributable to Parent 1.62B USD +24.7%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 1.48B USD +144%
Liabilities and Equity 3.35B USD +8.57%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 199M USD +7.98%
Net Cash Provided by (Used in) Financing Activities -144M USD +1.37%
Net Cash Provided by (Used in) Investing Activities -107M USD -171%
Common Stock, Shares Authorized 120M shares 0%
Common Stock, Shares, Issued 108M shares +0.24%
Common Stock, Par or Stated Value Per Share 0.1 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -56.5M USD -4692%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 309M USD -6.95%
Deferred Tax Assets, Valuation Allowance 34.8M USD -12.4%
Deferred Tax Assets, Gross 246M USD +33.9%
Operating Lease, Liability 124M USD +2.49%
Payments to Acquire Property, Plant, and Equipment 30.3M USD -23.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 865M USD +4.4%
Lessee, Operating Lease, Liability, to be Paid 147M USD +2.56%
Property, Plant and Equipment, Gross 1.49B USD +9.71%
Operating Lease, Liability, Current 21M USD +5.38%
Lessee, Operating Lease, Liability, to be Paid, Year Two 26.2M USD +14.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 28.4M USD +10.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Deferred Income Tax Expense (Benefit) -2.57M USD +31.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 22.4M USD +2.98%
Lessee, Operating Lease, Liability, to be Paid, Year Three 20.7M USD +3.08%
Deferred Tax Assets, Operating Loss Carryforwards 9.01M USD +0.57%
Preferred Stock, Shares Authorized 500K shares 0%
Unrecognized Tax Benefits 22.3M USD -1.01%
Lessee, Operating Lease, Liability, to be Paid, Year Four 14.8M USD -2.54%
Operating Lease, Payments 7.16M USD -7.97%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 29.9M USD +5.55%
Deferred Tax Assets, Net of Valuation Allowance 212M USD +46.6%
Share-based Payment Arrangement, Expense 61.2M USD +5.82%
Interest Expense 36.4M USD -20.9%
Preferred Stock, Par or Stated Value Per Share 1 USD/shares 0%